Effect of Lidocaine and Ozone in Injection for Myofascial Pain

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 25, 2021

Primary Completion Date

January 14, 2024

Study Completion Date

September 27, 2024

Conditions
Myofascial Pain Syndromes
Interventions
DIAGNOSTIC_TEST

Headache Impact Test-6 (HIT-6)

Patients who had injections were asked to mark their headache severities with a survey includes six questions about their past 4 weeks. The test applied preoperatively, postoperatively 1st and 3rd months.

DIAGNOSTIC_TEST

Pittsburgh Sleep Quality Index (PSQI)

Patients who had injections were asked to reply some questions about their sleeping habits for past 4 weeks. The test applied preoperatively, postoperatively 1st and 3rd months.

DIAGNOSTIC_TEST

Visual Analogue Score (VAS)

Patients who had injections are asked to state their pain with a 10 cm visual analogue scale preoperatively and postoperatively 1st,2nd weeks and 1st and 3rd months.

OTHER

Masseter muscle injection

1 ml of insulin needle with a 27-gauge ½ inch 13 mm needle tip will be injected into up to 4 trigger points in the taut bands that cause the most pain in the masseter muscle. Injections were done at most 3 times. As the control group, the first group was injected with isotonic saline; the second group was injected with 2% lidocaine without vasoconstrictor; the third group with ozone gas; and the fourth group with ozonated isotonic saline.

Trial Locations (1)

34083

Istanbul Medipol University, Istanbul

All Listed Sponsors
collaborator

Istanbul Medipol University Hospital

OTHER

lead

Yağmur Malkoc

OTHER

NCT06768281 - Effect of Lidocaine and Ozone in Injection for Myofascial Pain | Biotech Hunter | Biotech Hunter